Clinical Trial Update: A Study of ZG005 Combined With Donafenib in Patients With Advanced Solid Tumor [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for ZG005 in combination with Donafenib in patients with advanced solid tumors, currently in Phase 1/2 and recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• Donafenib (donafenib)
• ZG005

Snippet

Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd | Conditions: Solid Tumor | Phase 1, Phase 2 | Status: RECRUITING